|
1
|
Siegel R, Naishadham D and Jemal A: Cancer
statistics, 2013. CA Cancer J Clin. 63:11–30. 2013. View Article : Google Scholar
|
|
2
|
Moghimi-Dehkordi B and Safaee A: An
overview of colorectal cancer survival rates and prognosis in Asia.
World J Gastrointest Oncol. 4:71–75. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Arasaradnam RP, Commane DM, Bradburn D and
Mathers JC: A review of dietary factors and its influence on DNA
methylation in colorectal carcinogenesis. Epigenetics. 3:193–198.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Beggs AD and Hodgson SV: The genomics of
colorectal cancer: state of the art. Curr Genomics. 9:1–10. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Fearon ER: Molecular genetics of
colorectal cancer. Ann Rev Pathol. 6:479–507. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Worthley DL and Leggett BA: Colorectal
cancer: molecular features and clinical opportunities. Clin Biochem
Rev. 31:31–38. 2010.PubMed/NCBI
|
|
7
|
Yuan BZ, Miller MJ, Keck CL, Zimonjic DB,
Thorgeirsson SS and Popescu NC: Cloning, characterization, and
chromosomal localization of a gene frequently deleted in human
liver cancer (DLC-1) homologous to rat RhoGAP. Cancer
Res. 58:2196–2199. 1998.PubMed/NCBI
|
|
8
|
Nagase T, Kikuno R, Hattori A, Kondo Y,
Okumura K and Ohara O: Prediction of the coding sequences of
unidentified human genes. XIX The complete sequences of 100 new
cDNA clones from brain which code for large proteins in
vitro. DNA Res. 7:347–355. 2012. View Article : Google Scholar
|
|
9
|
Guan M, Zhou X, Soulitzis N, Spandidos DA
and Popescu NC: Aberrant methylation and deacetylation of deleted
in liver cancer-1 gene in prostate cancer: potential clinical
applications. Clin Cancer Res. 12:1412–1419. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Durkin ME, Yuan BZ, Zhou X, Zimonjic DB,
Lowy DR, Thorgeirsson SS and Popescu NC: DLC-1: a Rho
GTPase-activating protein and tumour suppressor. J Cell Mol Med.
11:1185–1207. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Feng X, Li C, Liu W, Chen H, Zhou W, Wang
L, Zhu B, Yao K, Jiang X and Ren C: DLC-1, a candidate tumor
suppressor gene, inhibits the proliferation, migration and
tumorigenicity of human nasopharyngeal carcinoma cells. Int J
Oncol. 42:1973–1984. 2013.PubMed/NCBI
|
|
12
|
Zhang T, Zheng J, Jiang N, Wang G, Shi Q,
Liu C and Lu Y: Overexpression of DLC-1 induces cell apoptosis and
proliferation inhibition in the renal cell carcinoma. Cancer Lett.
283:59–67. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
van Amerongen R and Nusse R: Towards an
integrated view of Wnt signaling in development. Development.
136:3205–3214. 2009.PubMed/NCBI
|
|
14
|
Jang KY, Kim YN, Bae JS, Chung MJ, Moon
WS, Kang MJ, Lee DG and Park HS: Expression of cyclin D1 is
associated with β-catenin expression and correlates with good
prognosis in colorectal adenocarcinoma. Transl Oncol. 5:370–378.
2012.
|
|
15
|
Lee HK and Jeong SJ: β-Catenin as a valid
molecular target for the development of therapeutic inhibitors.
JNBT. 2:29–37. 2005.
|
|
16
|
Pritchard CC and Grady WM: Colorectal
cancer molecular biology moves into clinical practice. Gut.
60:116–129. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar
|
|
18
|
Sengupta N, Gill KA, MacFie TS, Lai CS,
Suraweera N, Mcdonald S and Silver A: Management of colorectal
cancer: a role for genetics in prevention and treatment? Pathol Res
Pract. 204:469–477. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wu WK, Wang XJ, Cheng AS, Luo MX, Ng SS,
To KF, Chan FK, Cho CH, Sung JJ and Yu J: Dysregulation and
crosstalk of cellular signaling pathways in colon. Crit Rev Oncol
Hematol. 86:251–277. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Liao YC and Lo SH: Deleted in liver
cancer-1 (DLC-1): a tumor suppressor not just for liver. Int J
Biochem Cell Biol. 40:843–847. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wu PP, Jin YL, Shang YF, Jin Z, Wu P and
Huang PL: Restoration of DLC1 gene inhibits proliferation and
migration of human colon cancer HT29 cells. Ann Clin Lab Sci.
39:263–269. 2009.PubMed/NCBI
|
|
22
|
Ullmannova V and Popescu NC: Expression
profile of the tumor suppressor genes DLC-1 and DLC-2 in solid
tumors. Int J Oncol. 29:1127–1132. 2006.PubMed/NCBI
|
|
23
|
Wilson PJ, McGlinn E, Marsh A, Evans T,
Arnold J, Wright K, Biden K, Young J, Wainwright B, Wicking C and
Chenevix-Trench G: Sequence variants of DLC1 in colorectal
and ovarian tumours. Hum Mutat. 15:156–165. 2000.
|
|
24
|
Seidler HB, Utsuyama M, Nagaoka S,
Takemura T, Kitagawa M and Hirokawa K: Expression level of Wnt
signaling components possibly influences the biological behavior of
colorectal cancer in different age groups. Exp Mol Pathol.
76:224–233. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Doucas H, Garcea G, Neal CP, Manson MM and
Berry DP: Changes in the Wnt signalling pathway in gastrointestinal
cancers and their prognostic significance. Eur J Cancer.
41:365–379. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhou X, Thorgeirsson SS and Popescu NC:
Restoration of DLC-1 gene expression induces apoptosis and inhibits
both cell growth and tumorigenicity in human hepatocellular
carcinoma cells. Oncogene. 23:1308–1313. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Healy KD, Hodgson L, Kim TY, Shutes A,
Maddileti S, Juliano RL, Hahn KM, Harden TK, Bang YJ and Der CJ:
DLC-1 suppresses non-small cell lung cancer growth and invasion by
RhoGAP-dependent and independent mechanisms. Mol Carcinog.
47:326–337. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Jin Y, Tian X, Shang Y and Huang P:
Inhibition of DLC-1 gene expression by RNA interference in the
colon cancer LoVo cell line. Oncol Rep. 19:669–674. 2008.PubMed/NCBI
|
|
29
|
Kim PJ, Plescia J, Clevers H, Fearon ER
and Altieri DC: Survivin and molecular pathogenesis of colorectal
cancer. Lancet. 362:205–209. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Wu PP, Su Y, Jin Z, Wu P, Xu JJ and Huang
PL: Effects of DLC1 gene transfection on HT29 cell cycle
distribution: the role of Rho A. Southeast Univ (Med Sci Edi).
28:247–251. 2009.
|
|
31
|
Clevers H and Nusse R: Wnt/β-catenin
signaling and disease. Cell. 149:1192–1205. 2012.
|
|
32
|
MacDonald BT, Tamai K and He X:
Wnt/β-catenin signaling: components, mechanisms, and diseases. Dev
Cell. 7:9–26. 2009.
|
|
33
|
Kimelman D and Xu W: beta-catenin
destruction complex: insights and questions from a structural
perspective. Oncogene. 25:7482–7491. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Kawasaki Y, Sato R and Akiyama T: Mutated
APC and Asef are involved in the migration of colorectal tumour
cells. Nat Cell Biol. 5:211–215. 2003. View
Article : Google Scholar : PubMed/NCBI
|
|
35
|
Miyashiro I, Senda T, Matsumine A, Baeg
GH, Kuroda T, Shimano T, Miura S, Noda T, Kobayashi S and Monden M:
Subcellular localization of the APC protein: immunoelectron
microscopic study of the association of the APC protein with
catenin. Oncogene. 11:89–96. 1995.PubMed/NCBI
|
|
36
|
van de Wetering M, Sancho E, Verweij C, de
Lau W, Oving I, Hurlstone A, van der Horn K, Batlle E, Coudreuse D,
Haramis AP, Tjon-Pon-Fong M, Moerer P, van den Born M, Soete G,
Pals S, Eilers M, Medema R and Clevers H: The β-catenin/TCF-4
complex imposes a crypt progenitor phenotype on colorectal cancer
cells. Cell. 111:241–250. 2002.
|
|
37
|
Zhang T, Otevrel T, Gao Z, Gao Z, Ehrlich
SM, Fields JZ and Boman BM: Evidence that APC regulates survivin
expression: a possible mechanism contributing to the stem cell
origin of colon cancer. Cancer Res. 61:8664–8667. 2001.
|
